Steven Fruchtman | executive |
Victor Moyo | executive |
Mark Guerin | executive |
Edouard Mullarky | analyst |
Ahu Demir | analyst |
Joshua Korsen | analyst |
Robert LeBoyer | analyst |
James Molloy | analyst |
Meena Arora | executive |
Ladies and gentlemen, thank you for standing by. Welcome to Onconova Therapeutics Third Quarter 2023 Financial Results and Business Update Conference Call. [Operator Instructions] As a reminder, this call is being recorded today, November 14, 2023.At this time, I would like to turn the call over to Bruce Mackle of LifeSci Advisors.
Thank you, operator, and welcome, everyone, to Onconova's Third Quarter 2023 Financial Results and Business Update Conference Call. Earlier this afternoon, Onconova issued a press release reporting its financial results and business progress.